The oncogenic activities of mGluR1 expressing melanoma cells are independent of BRAF and NRAS mutations; additionally it has been found that a polymorphism in the GRM1 gene is predominately found in non-CSID melanoma patients [65,66,67]. The gene discussed is NRAS; the disease is melanoma.